ACE and dementia: A network meta-analysis of studies comparing dementia risks between users of different AHM classes suggests that users of angiotensin receptor blockers (ARBs) and calcium channel blockers (CCBs) had a 12–17% lower risk of dementia compared with individuals using angiotensin-converting enzyme (ACE) inhibitors and beta-blockers but less so versus diuretics [14].